Technology News and Research

RSS

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

Covidien, a leading global provider of healthcare products, today announced that its new Endo GIA curved tip and black reloads with Tri-Staple technology are available in limited release with a full U.S. roll out expected by mid-year.

1 Feb 2011

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

Abbott today announced it has received regulatory clearance in the United States and approval in Japan for its TREK and MINI-TREK Coronary Dilatation Catheters for the treatment of coronary artery disease. The TREK system is used in angioplasty procedures and is designed to enable interventional cardiologists to open patients' narrowed coronary arteries. The TREK system received CE Mark and was launched in Europe in May 2010.

1 Feb 2011

Cappella initiates multi-center Italian Sideguard open label clinical study

Cappella Medical Devices announces initiation of the multi-center Italian Sideguard® open label clinical study. The Principal Investigator (PI) of the study, Dr. Giuseppe Massimo Sangiorgi at the Policlinico di Modena - University of Modena and Reggio Emilia, in Modena, Italy stated, "The side branch ostium anatomy requires a unique technology solution to effectively manage and optimize treatment.

1 Feb 2011

FDA approves ultrasmall silica inorganic nanoparticle INDA for targeted molecular imaging of cancer

Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application from the US Food and Drug Administration for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

31 Jan 2011

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

Florida-based biopharmaceutical company Oragenics, today announced its intention to commence a second phase 1 clinical trial of SMaRT Replacement Therapy.

31 Jan 2011

Researchers to develop computer-assisted diagnosis tools for pathologists

Researchers are leveraging Ohio Supercomputer Center resources to develop computer-assisted diagnosis tools that will provide pathologists grading Follicular Lymphoma samples with quicker, more consistently accurate diagnoses.

31 Jan 2011

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the initiation of two studies to further evaluate the efficacy and safety of VB-111 in advanced cancers.

31 Jan 2011

Baxter launches OLIMEL emulsion for parenteral nutrition

Baxter International today announced the launch of OLIMEL emulsion for infusion in Canada at the American Society of Parenteral and Enteral Nutrition's Clinical Nutrition Week.

From Baxter International Inc. 31 Jan 2011

Revolutions Medical: Major breakthrough in automatic retractable prefilled safety syringe technology

Revolutions Medical Corporation announces a major breakthrough in automatic retractable prefilled safety syringe technology. Building on the Company's proprietary vacuum based technology, important improvements in performance have been made that will set a new gold standard for safety in automatic prefilled syringes.

31 Jan 2011

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Encision, a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its third fiscal quarter ended December 31, 2010.

31 Jan 2011

CircusFit, Ringling Bros, HOPSports announce new partnership to encourage kids to stay active, healthy

Ringling Bros. CircusFit and HOPSports announce new partnership that will allow children around the world to get physically fit while having fun. CircusFit will be powered by the HOPSports Training System combining circus skills with state of the art technology to encourage youth to stay active and healthy.

31 Jan 2011

Alexion announces acquisition of Taligen Therapeutics

Alexion Pharmaceuticals, announced that it has acquired Taligen Therapeutics, a privately held development-stage biotechnology company based in Cambridge, Mass.

31 Jan 2011

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces the commercial availability in Europe of the self- anchoring Perceval S aortic heart valve. The innovative next-generation valve represents the latest innovation in heart valve technology.

31 Jan 2011

Blind individual drives street vehicle independently

The National Federation of the Blind, the oldest and largest organization of blind people in the nation, announced today that for the first time a blind individual has driven a street vehicle in public without the assistance of a sighted person.

30 Jan 2011

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

Scripps Research Institute scientists have converted adult skin cells directly into beating heart cells efficiently without having to first go through the laborious process of generating embryonic-like stem cells. The powerful general technology platform could lead to new treatments for a range of diseases and injuries involving cell loss or damage, such as heart disease, Parkinson's, and Alzheimer's disease.

30 Jan 2011

Chrissie Fletcher joins Pharma IQ to discuss about Health Technology Assessment

Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.

29 Jan 2011

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Apricus Biosciences, today announced that its research and development team at its NexMed, USA, Inc. subsidiary is presenting data demonstrating the use of the Company's proprietary NexACT technology to improve less permeable or less soluable drugs, at the Controlled Release Society Product Development Forum for Poorly Soluble Drugs, being held January 27 to 29, 2011, in Miami, Florida.

29 Jan 2011

Published paper suggests some orthodontists may expose young patients to unnecessary radiation

Some orthodontists may be exposing young patients to unnecessary radiation when they order 3-D X-ray imaging for simple orthodontic cases before considering traditional 2-D imaging, suggests a paper published by University of Michigan faculty.

29 Jan 2011

Viral Genetics enters binding Release and Settlement Agreement with T&T

Viral Genetics, and its President, Haig Keledjian, have entered into a binding Release and Settlement Agreement with Timothy and Thomas LLC and its principals that was approved by the court.

29 Jan 2011

Technology News and Research

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

Cappella initiates multi-center Italian Sideguard open label clinical study

FDA approves ultrasmall silica inorganic nanoparticle INDA for targeted molecular imaging of cancer

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

Researchers to develop computer-assisted diagnosis tools for pathologists

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

Baxter launches OLIMEL emulsion for parenteral nutrition

Revolutions Medical: Major breakthrough in automatic retractable prefilled safety syringe technology

Encision reports gross profit margin increase in third quarter of fiscal year 2011

CircusFit, Ringling Bros, HOPSports announce new partnership to encourage kids to stay active, healthy

Alexion announces acquisition of Taligen Therapeutics

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Blind individual drives street vehicle independently

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

Chrissie Fletcher joins Pharma IQ to discuss about Health Technology Assessment

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Published paper suggests some orthodontists may expose young patients to unnecessary radiation

Viral Genetics enters binding Release and Settlement Agreement with T&T

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News